Nomura Small Cap Growth Fund on Tarsus Pharmaceuticals Inc.
Thesis
Tarsus weighed on quarterly performance as its share price declined. The fund nevertheless stated that the fundamental thesis remains intact and centers on the company's novel treatment platform. The position illustrates the strategy's willingness to retain a growth holding through short-term weakness when the underlying investment case has not changed.
“Tarsus Pharmaceuticals Inc. also weighed on performance as the stock declined despite maintaining its fundamental thesis around the company's novel treatment platform.”